REG1V.HE Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 18:29):

Stats
Dzisiejszy wolumen	17 355.00
Średni wolumen	25 596.00
Kapitalizacja rynkowa	702.58M
EPS	€0.140 ( 2024-04-25 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	38.29
ATR14	€0.0480 (0.18%)

Wolumen Korelacja

Długi: -0.09 (neutral)

Krótki: -0.90 (strong negative)

Signal:(47.515) Neutral

Revenio Group Oyj Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Revenio Group Oyj Korelacja - Waluta/Towar

0.83
( strong )

0.76
( moderate )

0.00
( neutral )

0.78
( moderate )

-0.73
( moderate negative )

Revenio Group Oyj Finanse

Annual	2023
Przychody:	€96.60M
Zysk brutto:	€45.30M (46.89 %)
EPS:	€0.720

FY	2023
Przychody:	€96.60M
Zysk brutto:	€45.30M (46.89 %)
EPS:	€0.720

FY	2022
Przychody:	€96.98M
Zysk brutto:	€69.77M (71.95 %)
EPS:	€0.820

FY	2021
Przychody:	€78.78M
Zysk brutto:	€55.76M (70.77 %)
EPS:	€0.652

Financial Reports:

No articles found.

Revenio Group Oyj

Revenio Group Oyj, a health technology company, designs, manufactures, and sells ophthalmic diagnostics and devices for the detection of glaucoma, macular degeneration, diabetic retinopathy, and cataracts in Finland, rest of Europe, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; DRSplus, a device for detection of diabetic retinopathy; iCare MAIA, a microperimeter to measure the visual field; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. It also provides Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.